Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Health plan receivable, allowance for credit loss $ 150 $ 0
Clinic fees and insurance receivable, allowance for credit loss 5,683 5,755
Variable Interest Entity, Primary Beneficiary    
Assets to settle obligations 2,000 3,100
Liabilities without recourse to company assets 16,800 9,900
Investment in affiliates $ 31,400 $ 33,000
Class A Common Stock    
Common stock par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock shares authorized (in shares) 800,000,000 800,000,000
Common stock shares issued (in shares) 41,579,000 41,579,000
Common stock shares outstanding (in shares) 41,579,000 41,579,000
Class V Common Stock    
Common stock par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock shares authorized (in shares) 205,000,000 205,000,000
Common stock shares issued (in shares) 201,867,000 201,592,000
Common stock shares outstanding (in shares) 201,867,000 201,592,000